Concepedia

John A. Zebala

JA

31

Publications

2.5K

Citations

18

H-Index

1991

Active since

Affiliations

Syntrix Biosystems (United States)(Current)

The University of Texas MD Anderson Cancer Center

Hearst (United States)

University of Washington

Cornell University

John A. Zebala is an author at Syntrix Biosystems (United States) specializing in medicine, natural sciences, and biochemistry.

Top concepts

MedicineNatural SciencesImmunologyBiochemistryCell BiologyPharmacologyImmunotherapyOncologyDrug DiscoveryPharmacotherapy

Publications per year

1991–2024

31

Publications

31

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Wenting Liao, Michael J. Overman, Adam T. Boutin et al. · Cancer Cell · 2019 · 580 citations · Full text

Immune Therapy Resistance, Medicine, Immunology +7

Effective combinatorial immunotherapy for castration-resistant prostate cancer

Xin Lü, James W. Horner, Erin Paul et al. · Nature · 2017 · 536 citations · Full text

Urology, Genitourinary Cancer, Medicine +5

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz et al. · Clinical Cancer Research · 2019 · 263 citations · Full text

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy

Lillian Sun, Paúl E. Clavijo, Yvette Robbins et al. · JCI Insight · 2019 · 228 citations · Full text

Myeloid-derived Suppressor Cell, T-regulatory Cell, Immunology +18

Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC

Julia Kargl, Xiaodong Zhu, Huajia Zhang et al. · JCI Insight · 2019 · 183 citations · Full text

Rows per page

1–5 of 31